Gene · 23607
NIH grants1,872
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,872
Download this page as JSON| Grant | Title | CD2AP papers | Newest fiscal year |
|---|---|---|---|
| R01AG058854 | ENIGMA World Aging Center | 1 | 2025 |
| R01AG061111 | Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArTâHS) | 1 | 2025 |
| R01AG061800 | Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease | 1 | 2025 |
| R01AG071470 | Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease | 1 | 2025 |
| R01AG071514 | Multicultural Community Dementia Screening | 1 | 2025 |
| R01AG072120 | The brain multi-omic approach to identify key molecular drivers of neuropsychiatric symptoms in Alzheimer's dementia | 1 | 2025 |
| R01AG072547 | The Origins of Alzheimer Disease in African Americans | 1 | 2025 |
| R01AG073121 | BAG3 regulates Rab35 and the ESCRT/endolysosome pathway | 1 | 2025 |
| R01AG074009 | Decoding the impact of sex differences on Alzheimer's disease risk | 1 | 2025 |
| R01AG075827 | Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease | 1 | 2025 |
| R01AG076838 | The VETSA Longitudinal MRI Twin Study of Aging (VETSA MRI 4) | 1 | 2025 |
| R01AG079170 | Air pollution and early signs of dementia | 1 | 2025 |
| R01AI077505 | Pharmacogenomics of HIV Therapy | 1 | 2025 |
| R01AI128775 | Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data | 1 | 2025 |
| R01AI130152 | The transcription factor c-MYC in lymphocyte expansion and restriction of stemness | 1 | 2025 |
| R01AI150931 | Manipulation of host factors that promote HCMV latency | 1 | 2025 |
| R01AI153076 | Regulation of host immunity to impact virus persistence | 1 | 2025 |
| R01AI153348 | HCMV GPCR functions during latency and reactivation | 1 | 2025 |
| R01AI162631 | Interplay between influenza virus and S1P-metabolizing enzymes | 1 | 2025 |
| R01CA154663 | TGFbeta-regulated epithelial-mesenchymal transition (EMT) | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/grants?page=9